Severe First Trimester Recurrent Intrahepatic Cholestasis of Pregnancy: A Case Report and Literature Review

Abstract

Background Intrahepatic cholestasis of pregnancy (ICP) is a disorder of defective bile acid transport that results in systemic accumulation of bile acids and typically presents in the third trimester of pregnancy with intense pruritus. A positive linear correlation exists between total bile acid level and poor pregnancy outcome, and labor is typically induced at 37 weeks gestation to prevent intrauterine fetal demise (IUFD).

Case Study We present the most severe reported case of recurrent ICP presenting early in the first trimester. The patient was delivered by repeat cesarean section at 31 ^6/7 weeks gestation resulting in a viable female infant.

Conclusion Iatrogenic preterm delivery may be indicated in early-severe recurrent ICP to prevent IUFD, but more research is needed.

Keywords

severe recurrent ICP - first trimester - intrauterine fetal demise - preterm birth

• References

• 1 Glantz A, Marschall H-U, Mattsson L-A. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004; 40 (2) 467-474
• 2 Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009; 15 (17) 2049-2066
• 3 Kirkinen P, Ryynänen M. First-trimester manifestation of intrahepatic cholestasis of pregnancy and high fetoplacental hormone production in a triploid fetus. A case report. J Reprod Med 1995; 40 (6) 471-473
• 4 Brites D, Rodrigues CM, Cardoso MdaC, Graça LM. Unusual case of severe cholestasis of pregnancy with early onset, improved by ursodeoxycholic acid administration. Eur J Obstet Gynecol Reprod Biol 1998; 76 (2) 165-168
• 5 Chao TT, Sheffield JS. Primary dermatologic findings with early-onset intrahepatic cholestasis of pregnancy. Obstet Gynecol 2011; 117 (2 Pt 2): 456-458
• 6 Konjeti R, Selsky N. Intrahepatic cholestasis of pregnancy: a case report. Conn Med 2012; 76 (3) 163-164
• 7 Steele G. Reflection on a pregnancy complicated by obstetric cholestasis. Pract Midwife 2012; 15 (9) 30-32
• 8 Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med 1998; 339 (17) 1217-1227
• 9 Lee RH, Incerpi MH, Miller DA, Pathak B, Goodwin TM. Sudden fetal death in intrahepatic cholestasis of pregnancy. Obstet Gynecol 2009; 113 (2 Pt 2): 528-531
• 10 Rodrigues CMP, Marín JJG, Brites D. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment. Gut 1999; 45 (3) 446-452
• 11 Williamson C, Gorelik J, Eaton BM, Lab M, de Swiet M, Korchev Y. The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death in obstetric cholestasis. Clin Sci (Lond) 2001; 100 (4) 363-369
• 12 Roncaglia N, Arreghini A, Locatelli A, Bellini P, Andreotti C, Ghidini A. Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol Reprod Biol 2002; 100 (2) 167-170
• 13 He J, Chen L, Liang C. Clinical analysis of fetal death cases in intrahepatic cholestasis of pregnancy [in Chinese]. Zhonghua Fu Chan Ke Za Zhi 2011; 46 (5) 333-337